X

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Director/Senior Director, Development Program Management - CMC

Program ManagementConfirmed live in the last 24 hours
Full-timeRemote

About the Job

Requirements

  • A bachelor's degree in a scientific, technical, or related discipline is required; an advanced degree is preferred.
  • Typically requires 10 or more years of relevant biotechnology or pharmaceutical industry experience for Director level, or 12 or more years for Senior Director level, including significant experience in CMC, pharmaceutical development, technical operations, or related drug development environments.
  • Small molecule drug substance and drug product development experience is required.
  • Demonstrated experience managing cross-functional CMC deliverables, timelines, risks, and documentation in support of early-stage regulatory submissions, including regulatory applications.
  • Proven ability to influence without authority, drive alignment across technical and non-technical stakeholders, and ensure execution discipline across complex, matrixed Product Development Teams.
  • Experience developing and maintaining CMC-specific project plans, dashboards, milestone charts, action logs, risk logs, and related project management tools is required.
  • Proficiency with Smartsheet, Microsoft Project, Microsoft Office, and related project management tools is required.

Responsibilities

  • Partner with CMC, Development Program Managers, Program Team Leaders, and functional stakeholders to translate program strategy into integrated CMC execution plans for multiple early-stage compounds.
  • Lead project management for assigned compounds, including new molecules, technology transfer, scale-up, lifecycle management, and other development initiatives, ensuring alignment of scope, timelines, milestones, dependencies, deliverables, and risks with overall compound strategy.
  • Develop, baseline, and maintain project management tools and reporting, including CMC project plans, dashboards, milestone charts, action logs, risk logs, status reports, and financial tracking, as appropriate.
  • Drive execution of compound CMC strategy through effective meeting management, decision and action documentation, follow-up with accountable owners, and clear communication of progress, risks, issues, and key decisions with the Product Development Team.
  • Monitor project progress, identify risks or execution gaps, and partner with stakeholders to develop mitigation plans, escalation recommendations, and decision-ready updates in partnership with the Development Program Manager.
  • The role may be a member of the Product Development Team.
  • Improve CMC project management effectiveness through scalable tools, templates, Smartsheet solutions, automation, artificial intelligence-enabled approaches, and other process improvements that enhance planning, visibility, and execution.
  • Act in accordance with company policies, including the Code of Business Conduct and Ethics, and ensure policies are understood and followed by direct reports, if any.
  • Some international travel may be required.
  • Perform other duties as assigned.

Desired Qualifications

  • An advanced degree is preferred.
  • Experience with active pharmaceutical ingredient development and solid oral dosage forms is strongly preferred.
  • Exposure to New Drug Application, Marketing Authorization Application, or other late-stage submission activities is preferred.
  • Project Management Professional certification or equivalent project management training is preferred.

About the Company

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for neurological disorders, especially epilepsy, through research and collaboration with partners and licensors to support eventual product commercialization. Its drug candidates are designed to treat CNS and genetic contributors to disease, with examples like XEN007 reaching Phase 2 proof-of-concept in treatment-resistant pediatric childhood absence epilepsy, illustrating targeted therapeutic development. The company concentrates on genetics-informed neurology and maintains a pipeline funded in part by partnerships and licensing, setting it apart from broader pharma players. Its goal is to discover, develop, and bring therapies to patients to address unmet needs in neurology and epilepsy.

Company size
201-500
Company stage
IPO
Headquarters
Burnaby, Canada
Founded
1996

Recently Posted Jobs

Explore more opportunities at Xenon Pharmaceuticals

See more jobs